IndiaTickerLatest filing: Anuh Pharma Ltd - 506260 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2026.
ObservedCompany dossier
Anuh Pharma
NSE:ANUHPHR · ISIN INE489G01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Anuh Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹159.5 Cr · PAT ₹10.3 Cr.
Exchange XBRLLatest ownership: promoter group 71.80% and public 28.20% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Anuh Pharma Ltd - 506260 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2026.
BSE · financial results
Observed
Source filing Annual Report FY 2025-2026 - Anuh Pharma Limited
NSE · annual report
Observed
Archived filing Annual Report 2026 - Anuh Pharma Ltd.,
BSE · annual report
Observed
Source filing Shareholders meeting - Anuh Pharma Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹159.5 Cr
- Profit after tax
- ₹10.3 Cr
- EPS
- ₹2.06
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 71.80%
- Public
- 28.20%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL